Summary: In a randomised trial in gestational diabetes, a lifestyle intervention delivered through a medical Internet-of-Things self-management model lowered fasting glucose and weight gain, improved glucose and lipid metabolism, and reduced preeclampsia, preterm birth, neonatal hypoglycaemia, and macrosomia compared with standard lifestyle care.
PICO Summary
| Element | Detail |
|---|---|
| Population | 240 women with gestational diabetes enrolled, 225 completed (116 intervention, 109 control); single-centre, China. |
| Intervention | Lifestyle intervention via a medical Internet-of-Things self-management model (connected monitoring, data transmission, remote oversight). |
| Comparison | The same lifestyle interventions delivered conventionally, without mIoT. |
| Outcome | Significantly lower fasting glucose and gestational weight gain, and lower glucose- and lipid-metabolism indices. Rates of preeclampsia, preterm birth, neonatal hypoglycaemia, and fetal macrosomia were all lower in the intervention group. |
Expert Commentary
This is an encouraging trial in a setting where tighter control genuinely changes outcomes for two patients at once. Gestational diabetes is a condition where the gap between clinic visits is exactly when glucose drifts, so a connected self-management model that transmits data and enables remote feedback addresses a real weakness in usual care. The reported benefits are notable because they extend beyond glucose to the outcomes that matter clinically, less maternal weight gain and meaningfully fewer cases of preeclampsia, preterm birth, neonatal hypoglycaemia, and macrosomia. Fasting glucose, often the hardest parameter to tame in gestational diabetes, improved, which is reassuring. My caveats are the familiar ones for digital-health trials: this is a single-centre Chinese study whose specific platform is not fully described, the open-label design cannot blind a behavioural intervention, and access to the technology is itself a barrier to wider use. Can I use this with my patients? Yes, in spirit and increasingly in practice. It supports moving gestational diabetes care toward connected monitoring with app-enabled glucometers and structured remote review, while I keep in mind that the magnitude of benefit needs confirmation in more diverse, multicentre settings before being treated as definitive.
References
Wen J, Zhou L, Hu H, et al. Evaluation of a lifestyle intervention for women with gestational diabetes mellitus based on the medical internet of things: a randomized controlled trial with mid-sample verification. Hypertens Pregnancy. 2025;44(1):2552693. doi:10.1080/10641955.2025.2552693